You are here
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
Urbanscape: Single Shot Multi-Task 3D ReconstructionSBC: Dzyne Technologies Incorporated Topic: DTRA18B001
Hazard assessment tools that model the transport and dispersion of Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) materials through urban areas are only as good as the 3D models that inform the physics model. Maintaining accurate, up-to-date 3D models of urban areas is challenging. Even in the commercial world, urban construction and demolition may result in the models created a ...STTR Phase II 2020 Department of DefenseDefense Threat Reduction Agency
Semantic Parsing and role Labeling In Combination Effort (SPLICE)SBC: DECISIVE ANALYTICS CORPORATION Topic: DTRA14B003
To Counter Weapons of Mass Destruction (CWMD), DTRA must analyze data from numerous sources about a diverse set of technologies and activities. The extreme diversity in content and the volume of DTRAs data combine to produce one of the most challenging analysis problems in the government. The CWMD mission therefore requires deep analysis - an in-depth understanding of all available data and correl ...STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency
Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for TransfusionSBC: CYTOSORBENTS MEDICAL INC Topic: DHP15B001
Plasma from AB donors is considered universal as it can be transfused regardless of recipient blood type and is frequently used to rapidly resuscitate massively bleeding hospital trauma patients and warfighters with combat casualties. However supplies can be rapidly depleted as AB donors make up only 4% of the population. Therefore robust a technology to cost-effectively generate universal plasma ...STTR Phase II 2017 Department of DefenseDefense Health Agency
Portable System with Li Foil MWPC Neutron DetectorsSBC: RADIATION DETECTION TECHNOLOGIES INC Topic: DTRA14B005
At the completion of the research and development effort a Li-foil multi-wire proportional counter (MWPC) neutron detector with more than 625-cm2 of active area will be included in a portable radiation detection system. The system is expected to outperform the standards set by the ANSI N42.53 standards, and gamma-ray rejection ratio (GRR) of 1.0x10-8 or better. A gamma-ray spectrometer for isotope ...STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency
Discrete 3-D Electronics for Mobile Radiation Detection SystemsSBC: RADIATION DETECTION TECHNOLOGIES INC Topic: DTRA18B002
Phase II will utilize knowledge gained from phase I work to develop and execute a manufacturing process suitable for producing quantities of 3-D printed discrete circuits for radiation detection systems. The goal is to support mobile radiation detection system requirements for high voltage, analog amplification, and MCA functionality to produce differential pulse height spectra in time sequence. ...STTR Phase II 2020 Department of DefenseDefense Threat Reduction Agency
Production of Chemical Reagents for Prompt-Agent-Defeat WeaponsSBC: Nalas Engineering Services Inc Topic: DTRA14B001
Nalas Engineering and Johns Hopkins University collaborated in a Phase I STTR program to study reactive mixtures of HI3O8 and nanocomposite fuels previously developed by the Weihs Group. These fuel/oxidizer mixtures are uniquely able to simultaneously produce heat and biocidal iodine gas, a combination designed to destroy biological weapons. The team at Nalas focused on evaluating conditions for p ...STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency
Circulating Diagnostic Markers of Infectious DiseaseSBC: PATHOVACS INCORPORATED Topic: CBD18A001
Assays for accurate diagnosis of early stages of infection with biothreat agents, on the day of infection or within a few days of infection, will find wide use in both civilian and military applications These diagnostic assays, which are anticipated to be highly specific and sensitive, will add to the repertoire of tools of hospitals and clinics that serve our armed forces personnel deployed on th ...STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense